Antiretroviral therapy 2000

被引：4
|
作者：
Samuel, R [1 ]
Suh, B [1 ]
机构：
[1] Temple Univ Hosp & Med Sch, Infect Dis Sect, Philadelphia, PA USA
来源：
ARCHIVES OF PHARMACAL RESEARCH | 2000年 / 23卷 / 05期
关键词：
HIV; antiretroviral therapy; viral load; CD4; count; nucleoside reverse transcriptase inhibitors; non nucleoside reverse transcriptase inhibitors; protease inhibitors;
D O I：
10.1007/BF02976566
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
As we enter the new millennium, there have been dramatic improvements in the care of patients with HIV infection. These have prolonged life and decreased morbidity and mortality. There are fourteen currently available antiretrovirals approved in the United States for the treatment of this infection. The medications, including their pharmacokinetic properties, side effects, and dosing are reviewed. In addition, the current approach to the use of these medicines is discussed.
引用
收藏
页码：425 / 437
页数：13
相关论文
共 50 条
  • [31] Racial Differences in Changes of Metabolic Parameters and Body Composition in Antiretroviral Therapy-Naive Persons Initiating Antiretroviral Therapy
    Gibert, Cynthia L.
    Shlay, Judith C.
    Sharma, Shweta
    Bartsch, Glenn
    Peng, Grace
    Grunfeld, Carl
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009, 50 (01) : 44 - 53
  • [32] Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort Study
    McClean, Alison R.
    Trigg, Jason
    Cardinal, Claudette
    Loutfy, Mona
    Cooper, Curtis
    Kroch, Abigail
    Shokoohi, Mostafa
    Machouf, Nima
    Thomas, Rejean
    Klein, Marina B.
    Kelly, Deborah, V
    Wong, Alexander
    Sanche, Stephen
    Montaner, Julio S. G.
    Hogg, Robert S.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2022, 75 (04) : 309 - 316
  • [33] CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era
    Roul, Helene
    Mary-Krause, Murielle
    Ghosn, Jade
    Delaugerre, Constance
    Pialoux, Gilles
    Cuzin, Lise
    Launay, Odile
    Lacombe, Jean-Marc
    Menard, Amelie
    De Truchis, Pierre
    Delfraissy, Jean-Francois
    Weiss, Laurence
    Costagliola, Dominique
    AIDS, 2018, 32 (17) : 2605 - 2614
  • [34] Antiretroviral therapy and tuberculosis: does the regimen matter?
    van Leth, Frank
    Wit, Ferdinand W. N. M.
    Hermans, Sabine M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2014, 12 (01) : 5 - 7
  • [35] Managing antiretroviral therapy in the elderly HIV patient
    Guaraldi, Giovanni
    Pintassilgo, Ines
    Milic, Jovana
    Mussini, Cristina
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (12) : 1171 - 1181
  • [36] When to start antiretroviral therapy: as soon as possible
    Franco, Ricardo A.
    Saag, Michael S.
    BMC MEDICINE, 2013, 11
  • [37] Potential impact of early antiretroviral therapy on transmission
    Pao, David
    Pillay, Deenan
    Fisher, Martin
    CURRENT OPINION IN HIV AND AIDS, 2009, 4 (03) : 215 - 221
  • [38] Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy
    Page, I. D.
    McKew, S. J.
    Kudzala, A. G.
    Fullwood, C.
    van Oosterhout, J. J.
    Bates, I.
    INTERNATIONAL JOURNAL OF STD & AIDS, 2013, 24 (06) : 449 - 453
  • [39] Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
    Dean, GL
    Edwards, SG
    Ives, NJ
    Matthews, G
    Fox, EF
    Navaratne, L
    Fisher, M
    Taylor, GP
    Miller, R
    Taylor, CB
    de Ruiter, A
    Pozniak, AL
    AIDS, 2002, 16 (01) : 75 - 83
  • [40] Using HIV Viral Load From Surveillance to Estimate the Timing of Antiretroviral Therapy Initiation
    Braunstein, Sarah L.
    Robertson, McKaylee M.
    Myers, Julie
    Nash, Denis
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (02) : 222 - 227
12345